TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons

Pattern Recognition Receptors and Inflammation

Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · see citing works

A Toll-like receptor recognizes bacterial DNA

Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · see citing works

Circulating mitochondrial DAMPs cause inflammatory responses to injury

Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · see citing works

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · see citing works

A Gene Network Regulating Lysosomal Biogenesis and Function

Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · see citing works

Conditional gene targeting in macrophages and granulocytes using LysMcre mice

Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,143 · see citing works

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

The mitochondrial genome: structure, transcription, translation and replication

Taanman, J.-W. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00161-3 · Cited by 1,635 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201 · see citing works

Microglial cell origin and phenotypes in health and disease

Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · see citing works

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · see citing works

Innate immunity in the central nervous system

Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · see citing works

Neuroendocrine Regulation of Immunity

Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957 · see citing works

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works

A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death

Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 859 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes

Kim, Y., Brinkmann, M. M., Paquet, M.-È., & Ploegh, H. L. (2008) · Nature · doi:10.1038/nature06726 · Cited by 699 · see citing works

A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688 · see citing works

Etiology and pathogenesis of Parkinson's disease

Schapira, A. H. V., & Jenner, P. G. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 659 · see citing works

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors

Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · see citing works

A rotarod test for evaluation of motor skill learning

Shiotsuki, H., Yoshimi, K., Shimo, Y., Funayama, M., Takamatsu, Y., Ikeda, K., Takahashi, R., Kitazawa, S., & Hattori, N. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.03.026 · Cited by 627 · see citing works

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor

Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 616 · see citing works

A calculated response: control of inflammation by the innate immune system

Barton, G. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34431 · Cited by 532 · see citing works

Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9

Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y., & Ploegh, H. L. (2008) · Nature Immunology · doi:10.1038/ni.1669 · Cited by 478 · see citing works

Ligand-induced conformational changes allosterically activate Toll-like receptor 9

Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 462 · see citing works

The pathogenesis of cell death in Parkinson's disease

Jenner, P. G., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 451 · see citing works

The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling

Brinkmann, M. M., Spooner, E., Hoebe, K. H. N., Beutler, B., Ploegh, H. L., & Kim, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 444 · see citing works

Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

Ghosh, A., Roy, A., Liu, X., Kordower, J. H., Mufson, E. J., Hartley, D. M., Ghosh, S., Mosley, R. L., Gendelman, H. E., & Pahan, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704908104 · Cited by 438 · see citing works

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease

Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, É. C., Przedborski, S., RAKIC, P. T., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 427 · see citing works

Glia: Initiators and progressors of pathology in Parkinson's disease

Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 423 · see citing works

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 393 · see citing works

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

Dehmer, T., Heneka, M. T., Sastre, M., DICHGANS, J., & Schulz, J. B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382 · see citing works

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

Guiducci, C., Gong, M., Xu, Z., Gill, M. A., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T. B., Punaro, M., Bolland, S. M., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380 · see citing works

HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration

Gao, H.-M., Zhou, H., Zhang, F., Wilson, B. C., Kam, W., & Hong, J.-S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3732-10.2011 · Cited by 369 · see citing works

Twenty-Four Hour Cortisol Release Profiles in Patients With Alzheimer's and Parkinson's Disease Compared to Normal Controls: Ultradian Secretory Pulsatility and Diurnal Variation

Hartmann, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80309-0 · Cited by 319 · see citing works

Viral parkinsonism

Jang, H., Boltz, D. A., Webster, R. G., & Smeyne, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.001 · Cited by 289 · see citing works

Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells

Sepulveda, F. E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon‐Duménil, A., Amigorena, S., Cabanié, L., & Manoury, B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.013 · Cited by 280 · see citing works

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy

Tuckermann, J. P., Kleiman, A., Moriggl, R., Spanbroek, R., Neumann, A., Illing, A., Clausen, B. E., Stride, B., Förster, I., Habenicht, A. J. R., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28034 · Cited by 252 · see citing works

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · see citing works

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy

Tuckermann, J. P., Kleiman, A., Moriggl, R., Spanbroek, R., Neumann, A., Illing, A., Clausen, B. E., Stride, B. D., Förster, I., Habenicht, A. J. R., et al. (2007) · HAL · Cited by 224 · see citing works

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205 · see citing works

Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling

Park, B., Buti, L., Lee, S., Matsuwaki, T., Spooner, E., Brinkmann, M. M., Nishihara, M., & Ploegh, H. L. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.018 · Cited by 176 · see citing works

Inflammation in Parkinson’s disease: role of glucocorticoids

Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175 · see citing works

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease

Ip, C. W., Klaus, L.-C., Karikari, A. A., Visanji, N. P., Brotchie, J. M., Lang, A. E., Volkmann, J., & Koprich, J. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0416-x · Cited by 173 · see citing works

Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation

Monier, A., Evrard, P., Gressèns, P., & Verney, C. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21123 · Cited by 169 · see citing works

The role of inflammation in sporadic and familial Parkinson’s disease

Deleidi, M., & Gasser, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1352-y · Cited by 167 · see citing works

A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion

Boix, J., Padel, T., & Paul, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.053 · Cited by 162 · see citing works

Analysis of dopamine transporter gene expression pattern − generation of DAT‐iCre transgenic mice

Turiault, M., Parnaudeau, S., Milet, A., Parlato, R., Rouzeau, J., Lazar, M., & Tronche, F. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05886.x · Cited by 114 · see citing works

Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation

Carrillo-de Sauvage, M. Á., Maatouk, L., Arnoux, I., Pasco, M., Sanz Diez, A., Delahaye, M., Herrero, M. T., Newman, T. A., Calvo, C. F., Audinat, E., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.108 · Cited by 114 · see citing works

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

Santoro, M., Maetzler, W., Stathakos, P., Martin, H. L., Hobert, M. A., Rattay, T. W., Gasser, T., Forrester, J. V., Berg, D., Tracey, K. J., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.018 · Cited by 107 · see citing works

The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration

Deleidi, M., Hallett, P. J., Koprich, J. B., Chung, C. Y., & Ole Isacson, A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2400-10.2010 · Cited by 101 · see citing works

Rapid isolation of animal mitochondrial DNA by alkaline extraction

Palva, T. K., & Palva, E. T. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80122-8 · Cited by 100 · see citing works

Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease

Dai, Y.-B., Tan, X.-J., Wu, W.-F., Warner, M. N., & Gustafsson, J.-Α. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210833109 · Cited by 98 · see citing works

Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14

Nadeau, S., & Rivest, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3370 · Cited by 94 · see citing works

Genetic causes of Parkinson's disease and their links to autophagy regulation

Pan, P., & Yue, Z. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70037-3 · Cited by 52 · see citing works

Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease

Podlesniy, P., Vilas, D., Taylor, P., Shaw, L. M. J., Tolosa, E., & Trullás, R. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.019 · Cited by 45 · see citing works

The effect of dopamine on MPTP-induced rotarod disability

Ayton, S., George, J. L., Adlard, P. A., Bush, A. I., Cherny, R. A., & Finkelstein, D. I. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.066 · Cited by 38 · see citing works

Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia

Rabey, J. M., Scharf, M., Oberman, Z., Zohar, M., & Graff, E. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90525-7 · Cited by 36 · see citing works

The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers

Shaker, M. E., Trawick, B. N., & Mehal, W. Z. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.003 · Cited by 34 · see citing works

A Novel Small-Molecule Enantiomeric Analogue of Traditional (−)-Morphinans Has Specific TLR9 Antagonist Properties and Reduces Sterile Inflammation-Induced Organ Damage

Hoque, R., Farooq, A., Malik, A. F., Trawick, B. N., Berberich, D. W., McClurg, J. P., Galen, K. P., & Mehal, W. Z. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202184 · Cited by 34 · see citing works

TLR9 regulation by proteolysis: A friend or a foe

Manoury, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201141858 · Cited by 13 · see citing works

Role of neuroinflammation in neurodegeneration development

Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works

Microglia and astrocyte dysfunction in parkinson's disease

Kam, T., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 399 · see citing works

Dopamine, Immunity, and Disease

Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 325 · see citing works

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275 · see citing works

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery

Picca, A., Guerra, F., Calvani, R., Romano, R., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Biomolecules · doi:10.3390/biom11101508 · Cited by 189 · see citing works

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11928-w · Cited by 188 · see citing works

Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles

Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183 · see citing works

The Role of Glucocorticoids in Inflammatory Diseases

Reichardt, S. D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J. P., Lühder, F., & Reichardt, H. M. (2021) · Cells · doi:10.3390/cells10112921 · Cited by 180 · see citing works

Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies

Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143 · see citing works

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists

Federico, S., Pozzetti, L., Papa, A., Carullo, G., Gemma, S., Butini, S., Campiani, G., & Relitti, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01049 · Cited by 120 · see citing works

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions

Squillace, S., & Salvemini, D. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.05.004 · Cited by 117 · see citing works

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease

Hallett, P. J., Engelender, S., & Ole Isacson, A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 105 · see citing works

Formation of memory assemblies through the DNA-sensing TLR9 pathway

Jovasevic, V., Wood, E. M., Cicvaric, A., Zhang, H., Petrovic, Z., Carboncino, A., Parker, K., Bassett, T. E., Moltesen, M., Yamawaki, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07220-7 · Cited by 98 · see citing works

In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma

Wang, X., Ye, L., He, W., Teng, C., Sun, S., Lu, H., Li, S., Lv, L., Cao, X., Yin, H., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.050 · Cited by 80 · see citing works

TRP Channels Role in Pain Associated With Neurodegenerative Diseases

Duitama, M., Vargas-López, V., Casas, Z., Albarracín, S. L., Sutachan, J. J., & Torres, Y. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00782 · Cited by 80 · see citing works

Neuroendocrine, neuroinflammatory and pathological outcomes of chronic stress: A story of microglial remodeling

Picard, K., St‐Pierre, M., Vecchiarelli, H. A., Bordeleau, M., & Tremblay, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104987 · Cited by 79 · see citing works

The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives

Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 83 · see citing works

The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease

Yin, R. L., Xue, J., Tan, Y., Fang, C., Hu, C., Yang, Q., Mei, X., & Qi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9923331 · Cited by 79 · see citing works

Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders

Zhang, G., Wei, H., Zhao, A., Xu, Y., Zhang, X., Gan, J., Guo, M., Wang, J., Zhang, F., Jiang, Y., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03363-0 · Cited by 81 · see citing works

Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications

Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 72 · see citing works

TRPA1 Role in Inflammatory Disorders: What Is Known So Far?

Landini, L., de Araújo, D. S. M., Titiz, M., Geppetti, P., Nassini, R., & Logu, F. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094529 · Cited by 63 · see citing works

Glucocorticoids as Regulators of Macrophage-Mediated Tissue Homeostasis

Díaz-Jiménez, D., Kolb, J. P., & Cidlowski, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669891 · Cited by 55 · see citing works

Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis

Xiong, L., McCoy, M. G., Komuro, H., West, X. Z., Yakubenko, V. P., Gao, D., Dudiki, T., Milo, A., Chen, J. M., Podrez, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.031 · Cited by 51 · see citing works

Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury

Kang, H., Liu, Y., Li, Y., Wang, L., Zhao, Y., Yuan, R., Yang, M.-M., Chen, Y., Zhang, H., Zhou, F., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.363819 · Cited by 50 · see citing works

The Mammalian Cysteine Protease Legumain in Health and Disease

Solberg, R., Lunde, N. N., Forbord, K. M., Okla, M., Kassem, M. S., & Jafari, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415983 · Cited by 52 · see citing works

Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson’s Disease in Vitro

Cui, W., Zhan, Y., Shao, X., Fu, W., Xiao, D., Zhu, J., Qin, X., Zhang, T., Zhang, M., Zhou, Y., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10308 · Cited by 49 · see citing works

A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid

Han, N., Kim, Y.-K., Ahn, S., Hwang, T., Lee, H., & Park, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.599045 · Cited by 50 · see citing works

Early postnatal allergic airway inflammation induces dystrophic microglia leading to excitatory postsynaptic surplus and autism-like behavior

Saitoh, B.-Y., Tanaka, E., Yamamoto, N., Kruining, D. V., Iinuma, K., Nakamuta, Y., Yamaguchi, H., Yamasaki, R., Matsumoto, K., & Kira, J.-I. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.008 · Cited by 47 · see citing works

MicroRNAs Play a Role in Parkinson’s Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential

Li, S., Bi, G., Han, S., & Huang, R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.744942 · Cited by 45 · see citing works

Prevention of Oxidative Stress and Diseases by Antioxidant Supplementation

Martemucci, G., Portincasa, P., Centonze, V., Mariano, M., Khalil, M., & D‘Alessandro, A. G. (2022) · Medicinal Chemistry · doi:10.2174/1573406419666221130162512 · Cited by 44 · see citing works

Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy

Park, W., Seong, K., Han, H. H., Yang, S. Y., & Hahn, S. K. (2021) · RSC Advances · doi:10.1039/d1ra00747e · Cited by 40 · see citing works

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 39 · see citing works

Pharmacological targeting cGAS/STING/NF-κB axis by tryptanthrin induces microglia polarization toward M2 phenotype and promotes functional recovery in a mouse model of spinal cord injury

Fan, Z., Jia, M., Zhou, J. P., Zhu, Z., Wu, Y., Lin, X., Qian, Y., Lian, J., Hua, X., Dong, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01256 · Cited by 39 · see citing works

Inhibition of Microglial Activation in the Amygdala Reverses Stress-Induced Abdominal Pain in the Male Rat

Yuan, T., Manohar, K., Latorre, R., Orock, A., & Greenwood-Van Meerveld, B. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.020 · Cited by 35 · see citing works

Impact of sex on neuroimmune contributions to Parkinson’s disease

Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 34 · see citing works

Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases

Narayanankutty, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190222181506 · Cited by 29 · see citing works

Asparagine endopeptidase cleaves tau at N167 after uptake into microglia

Behrendt, A., Bichmann, M., Ercan-Herbst, E., Haberkant, P., Schöndorf, D. C., Wolf, M., Fahim, S. A., Murolo, E., & Ehrnhoefer, D. E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104518 · Cited by 26 · see citing works

Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications

García‐Domínguez, M. (2026) · Biomedicines · doi:10.3390/biomedicines14010115 · Cited by 29 · see citing works

Is Pre‐Symptomatic Immunosuppression Protective in CSF1R ‐ Related Leukoencephalopathy?

Tipton, P. W., Stanley, E. R., Chiţu, V., & Wszołek, Z. K. (2021) · Movement Disorders · doi:10.1002/mds.28515 · Cited by 25 · see citing works

Protective role of TLR 9‐induced macrophage/microglia phagocytosis after experimental intracerebral hemorrhage in mice

Wei, J., Dai, S., Pu, C., Luo, P., Yang, Y., Jiang, X., Li, X., Lin, W. J., & Fei, Z. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13919 · Cited by 23 · see citing works

Toll-like Receptors in Viral Encephalitis

Gern, O. L., Mulenge, F., Pavlou, A., Ghita, L., Steffen, I., Stangel, M., & Kalinke, U. (2021) · Viruses · doi:10.3390/v13102065 · Cited by 23 · see citing works

Host immune responses in the central nervous system during fungal infections

Reyes, E. Y., & Shinohara, M. L. (2022) · Immunological Reviews · doi:10.1111/imr.13101 · Cited by 22 · see citing works

Host-pathogen protein-nucleic acid interactions: A comprehensive review

Jain, A., Mittal, S., Tripathi, L. P., Nussinov, R., & Ahmad, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.001 · Cited by 21 · see citing works

MicroRNA-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson’s disease: a bioinformatics approach

Singh, G., & Khatri, D. K. (2024) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-024-00445-6 · Cited by 20 · see citing works

Glucocorticosteroids Effects on Brain Development in the Preterm Infant: A Role for Microglia?

Zinni, M., Pansiot, J., Billion, E., Baud, O., & Mairesse, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517112913 · Cited by 15 · see citing works

TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice

He, Y., Zhao, J., Dong, H., Zhang, X., Duan, Y., Ma, Y., Yu, M., Fei, J., & Huang, F. P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122171 · Cited by 13 · see citing works

What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?

Xue, J., Tao, K., Wang, W., & Wang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031641 · Cited by 16 · see citing works

α-synuclein in Parkinson’s disease: a central point of convergence with depression

Yusuf, A. M., İlçe, B. Y., Alhaj, H. A., & Hamoudi, R. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01167-w · Cited by 12 · see citing works

Mitochondrial Dysfunction in the Inflammatory Process of Neurodegenerative Diseases

Nesci, S. (2026) · Biomedicines · doi:10.3390/biomedicines14030682 · Cited by 12 · see citing works

An enriched environment reduces chronic stress-induced visceral pain through modulating microglial activity in the central nucleus of the amygdala

Yuan, T., Orock, A. M., & Meerveld, B. G. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00307.2021 · Cited by 12 · see citing works

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation

Habas, A., Natala, S. R., Bowden-Verhoek, J. K., Stocking, E. M., Price, D. L., Wrasidlo, W., Bonhaus, D. W., & Gill, M. B. (2022) · International Journal of Inflammation · doi:10.1155/2022/2337363 · Cited by 12 · see citing works

Activation of TLR7-mediated autophagy increases epileptic susceptibility via reduced KIF5A-dependent GABAA receptor transport in a murine model

Liu, J., Ke, P., Guo, H., Gu, J., Liu, Y., Tian, X., Wang, X., & Xiao, F. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01000-5 · Cited by 11 · see citing works

TLR9 activation in large wound induces tissue repair and hair follicle regeneration via γδT cells

Li, X., An, T., Yang, Y., Xu, Z., Chen, S., Yi, Z., Chen, D., Zhou, F., Man, Y., & Hu, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06994-y · Cited by 12 · see citing works

Graphene promotes lung cancer metastasis through Wnt signaling activation induced by DAMPs

Bi, Z., Li, L., Yang, J., Li, X., Mo, F., Lu, T., Song, Y., Cheng, Z., Fu, Q., Lei, H., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101175 · Cited by 11 · see citing works

Receptors on Microglia

Augusto‐Oliveira, M., Tremblay, M., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_6 · Cited by 10 · see citing works

Supramolecular organizing centers at the interface of inflammation and neurodegeneration

Sušjan, P., Ramuta, T. Ž., Boršić, E., Orehek, S., & Hafner‐Bratkovič, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940969 · Cited by 10 · see citing works

The role of vagus nerve stimulation in modulating Parkinson’s disease via the microbiota-gut-brain axis: a comprehensive review

Yang, L., Fan, S., Sun, L., Han, J., Wang, M., & Yu, T. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1643305 · Cited by 9 · see citing works

Immunoregulatory Functions of Nuclear Receptors: Mechanisms and Therapeutic Implications

Zhao, L., Gimple, R. C., Yang, Z., Wei, Y., Gustafsson, J.-Α., & Zhou, S. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.10.002 · Cited by 9 · see citing works

Crosstalk Between Mitochondrial DNA and Immune Response: Focus on Autism Spectrum Disorder

Qu, W., Yan, G., Du, Y., Zhou, X., Huang, C., Li, B., Zhou, J., & Li, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04637-z · Cited by 8 · see citing works

Cellular Communication Networks Mediated by Microglia in Ischemic Stroke

Ma, F., Bai, Y., Li, N., Cai, X., Xu, R., & Cao, X. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70687 · Cited by 8 · see citing works

Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice

Li, L., Fan, S., Zhang, W., Li, D., Yang, Z. Y., Zhuang, P., Han, J., Guo, H., & Zhang, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s316314 · Cited by 8 · see citing works

Broken strands, broken minds: Exploring the nexus of DNA damage and neurodegeneration

Stavgiannoudaki, I., Goulielmaki, E., & Garinis, G. A. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103699 · Cited by 8 · see citing works

Mechanism of Microglial Cell Activation in the Benzophenone-3 Exposure Model

Maciejska, A., Pomierny, B., Krzyżanowska, W., Starek‐Świechowicz, B., Skórkowska, A., & Budziszewska, B. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.10.002 · Cited by 7 · see citing works

P7C3-A20 Attenuates Microglial Inflammation and Brain Injury after ICH through Activating the NAD+/Sirt3 Pathway

Wu, Y., Hu, Q., Wu, X., Cai, Y., Zhang, Y.-Z., Wu, Y., Zhu, G., Luo, J., Cheng, H.-B., Yu, J., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7857760 · Cited by 7 · see citing works

Dual Targeting of TLR9 and cGAS-STING Pathways Attenuates Astrocyte Inflammatory Activation: Potential Implication in Multiple Sclerosis

Shao, W., Huo, X., Liu, X., Zhang, Q., Hao, X., & Zhang, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04529-1 · Cited by 6 · see citing works

The contribution of silencer variants to human diseases

Huang, D., & Ovcharenko, I. (2024) · Genome biology · doi:10.1186/s13059-024-03328-1 · Cited by 6 · see citing works

Neuronal toll like receptor 9 contributes to complete Freund’s adjuvant-induced inflammatory pain in mice

Chen, Y., Chen, H., Li, X., Mi, W., Chu, Y., Wang, Y., & Mao‐Ying, Q. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1008203 · Cited by 6 · see citing works

The Brain‐Gut Axis in Parkinson's Disease Pathology

Ozkaya, K. S., & Browning, K. N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70137 · Cited by 5 · see citing works

Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase

Calugi, L., Lenci, E., Bianchini, F., Contini, A., & Trabocchi, A. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116746 · Cited by 5 · see citing works

Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration

Birkle, T. J. Y., Willems, H. M. G., Skidmore, J., & Brown, G. C. (2024) · iScience · doi:10.1016/j.isci.2024.109454 · Cited by 4 · see citing works

Innate immunity in neurons makes memories persist

Kelvington, B. A., & Abel, T. G. (2024) · Nature · doi:10.1038/d41586-024-00679-4 · Cited by 3 · see citing works

Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists

Natala, S. R., Habas, A., Stocking, E. M., Orry, A. J. W., Abagyan, R. A., Makale, M., & Wrasidlo, W. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130259 · Cited by 3 · see citing works

Potential pharmacologic interventions targeting TLR signaling in placental malaria

Kobia, F., Maiti, K., Obimbo, M., Smith, R., & Gitaka, J. (2022) · Trends in Parasitology · doi:10.1016/j.pt.2022.04.002 · Cited by 3 · see citing works

Mitochondrial DNA leakage in aging: Mechanisms, pathological effects, and therapeutic horizons

Chen, Z., Wu, Q., Tian, Y., Gu, L. C. R. O. D. I., Liu, X., & Liu, J. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102134 · Cited by 2 · see citing works

Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in micePreprint

Santoscoy, M. C., Espinoza, P., Hanlon, K. S., Yang, L., Nieland, L., Ng, C., Badr, C. E., Hickman, S. E., de la Cruz, D., Griciuc, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614546 · Cited by 2 · see citing works

Rab27-dependent mitochondrial extrusion from dopaminergic neurons drives neuroinflammation and neurodegeneration in the MPTP mouse model of Parkinson's disease

Xu, Y., Li, J., Ma, S., Yang, T., Shen, Z., Li, M., & Huang, Q. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.01.053 · Cited by 1 · see citing works

Central nervous system safety risks and evaluation strategies for mucosal vaccines: A review

Li, Q., & Bai, G. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129084 · Cited by 1 · see citing works

Unmethylated Cytosine phosphate guanine DNA (CpG-DNA) exacerbates liver Kupffer cells (KCs) inflammation through Toll-like receptor 9 (TLR9) in diabetic ratsPreprint

Cai, S., Li, J., & Zhang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-280189/v1

Mikroglial Toll-benzeri Reseptörlerin Alzheimer ve Parkinson Hastalıklarındaki Rolü

Samur, D. N., & Özbey, G. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.981907

Neurodegenerative Disorders

Walz, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-48105-5_13

Comparative safety, pharmacokinetics, and off-target assessment of 1,1-bis(3′-indolyl)-1-(p-chlorophenyl) methane in mouse and dog: implications for therapeutic development

Rocha, S. M., Gustafson, D. L., Safe, S. H., & Tjalkens, R. B. (2024) · Toxicology Research · doi:10.1093/toxres/tfae059

Additional file 1 of The contribution of silencer variants to human diseases

Huang, D., & Ovcharenko, I. (2024) · Figshare · doi:10.6084/m9.figshare.26211326

Additional file 2 of The contribution of silencer variants to human diseases

Huang, D., & Ovcharenko, I. (2024) · Figshare · doi:10.6084/m9.figshare.26211646

Additional file 3 of The contribution of silencer variants to human diseases

Huang, D., & Ovcharenko, I. (2024) · Figshare · doi:10.6084/m9.figshare.26746436

ApoE-directed CpG nano-immunoadjuvant ameliorates Alzheimer's-like pathology in mice

Huang, X., Sun, Y.-Y., Qin, Y.-R., Chen, H., Pan, T.-T., Zhao, S., Cai, Q., Zhang, X., Nie, X.-D., Feng, L., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114687

Lisinopril activates BI1 to reprogram lipid metabolism and restore autophagy in ALS

Yin, H., Ren, Z., Zhang, Y., Wang, Y., Sun, Y., Fu, X., Yan, W., Zhang, F., & ZENG, L. (2026) · Communications Biology · doi:10.1038/s42003-026-09930-2

Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson

Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99

Targeting TLR9 reduces chronic stress-associated neuroinflammation and improves social behavior in a mouse model

Jose, D. A., Tripathi, A., Madeshiya, A. K., Todd, T., Quevedo, J., & Pillai, A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00248-7

The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention

Yin, Q., Ding, M., Tang, Y., Qi, Y., Qin, Y., Jin, H., Li, Y., Bao, J., Ma, S., Li, Y., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106325

Neuropsychiatric disorders in pulmonary fibrosis: from brain network alterations to inflammatory mechanisms and therapeutic implications

Li, C., Wang, L., Wang, F., Wang, L., Xu, L. H., Lyu, W., Shan, K., Li, J., Zhou, H., Rong, F., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03921-0

Regulation of the Mineralocorticoid Receptor in Physiology and Disease

Young, M. J., Fuller, P. J., Meijer, O. C., Cole, T. J., Kanki, M., Yang, J., Ho, Q. V., Karthigan, N., & Heanue, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100156

Mechanism analysis of MPTP-induced Parkinson's disease-like pathology via the HPA axis–microglial glucocorticoid receptor pathway

Xu, L., Xiao, K., Jiang, J., Tang, Y., Yang, L., Xiao, S., Jin, X., Xiao, B., Zhou, T., Hao, C., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120715

Immunogenic cell death in CNS diseases: From bench to bedside

Li, P., Zhou, Z., Qing, Y., Wei, X., Mei, Z., & Zhang, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103342

Before the insult: Why the microglial starting state matters in neurodegeneration

Szelechowski, M. (2026) · Glial health research. · doi:10.1016/j.ghres.2026.100022

Toll-like receptor signaling modulates AMPA receptor trafficking in homeostatic synaptic downscaling

Koga, A., 周平, 貴., & Matsuda, S. (2026) · The Journal of Physiological Sciences · doi:10.1016/j.jphyss.2026.100112

BindingDB Entry 50017218: Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase.

BindingDB (2023) · UC San Diego · doi:10.7270/q2qz2g1s

BindingDB Entry 50011884: Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.

BindingDB (2022) · UC San Diego · doi:10.7270/q2xs601n

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · see citing works

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431 · see citing works

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362 · see citing works

Immunomodulation of Mature Dendritic Cells in Parkinson's Disease: A Novel Role of Intracellular Toll Like Receptors

Paterniti, I., Campolo, M., Cordaro, M., Casili, G., Lanza, M., Filippone, A., Esposito, E., & Cuzzocrea, S. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.500.19

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease

Peng, Q., Zhang, G., Guo, X., Dai, L., Xiong, M., Zhang, Z., Chen, L., & Zhang, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1046992 · Cited by 12 · see citing works